FDA Approves Feasibility Study With Seastar Medical'S Selective Cytopheretic Device In Adults With Cardiorenal Syndrome

  • Kevin Chung

Press/Media

Period13 Jan 2025

Media coverage

16

Media coverage

  • TitleFDA Approves Feasibility Study With Seastar Medical'S Selective Cytopheretic Device In Adults With Cardiorenal Syndrome
    Media name/outletMENAFN -Press Releases (English)
    Country/TerritoryJordan
    Date13/01/25
    PersonsKevin Chung
  • TitleFDA Approves Feasibility Study with SeaStar Medical’s Selective Cytopheretic Device in Adults with Cardiorenal Syndrome
    Media name/outletADVFN UK
    Country/TerritoryUnited Kingdom
    Date13/01/25
    URLct.moreover.com/?a=55762697562&p=1gw&v=1&x=sPWmk8ePHeAaX_2uoxs3tg
    PersonsKevin Chung
  • TitleReuters FDA Approves Feasibility Study with SeaStar Medical’s Selective Cytopheretic Device in Adults with Cardiorenal Syndrome
    Media name/outletTradingView
    Country/TerritoryUnited States
    Date13/01/25
    URLct.moreover.com/?a=55762726661&p=1gw&v=1&x=hLuAZjuYDmpg-8rfV9vM-w
    PersonsKevin Chung
  • TitleFDA Approves Feasibility Study with SeaStar Medical’s Selective Cytopheretic Device in Adults with Cardiorenal Syndrome
    Media name/outletStockTitan.net
    Country/TerritoryUnited States
    Date13/01/25
    URLct.moreover.com/?a=55762727813&p=1gw&v=1&x=PbzkQCywieQb9aJ9e1RziA
    PersonsKevin Chung
  • TitleFDA Approves Feasibility Study with SeaStar Medical’s Selective Cytopheretic Device in Adults with Cardiorenal Syndrome
    Media name/outletYahoo! Finance
    Country/TerritoryUnited States
    Date13/01/25
    URLct.moreover.com/?a=55762762673&p=1gw&v=1&x=ODiYZQsTt5oMS9Dq1IYFwA
    PersonsKevin Chung
  • TitleFDA Approves Feasibility Study with SeaStar Medical's Selective Cytopheretic Device in Adults with Cardiorenal Syndrome
    Media name/outletStockwatch
    Country/TerritoryCanada
    Date13/01/25
    URLct.moreover.com/?a=55762690919&p=1gw&v=1&x=oEQhcowvj7JiYMBb_rZj5A
    PersonsKevin Chung
  • TitleFDA Approves Feasibility Study with SeaStar Medical’s Selective Cytopheretic Device in Adults with Cardiorenal Syndrome
    Media name/outletADVFN US
    Country/TerritoryUnited States
    Date13/01/25
    URLct.moreover.com/?a=55762693943&p=1gw&v=1&x=VkyCIl9DljIQpSYd7_mPvw
    PersonsKevin Chung
  • TitleSeaStar Medical Receives FDA Approval for SCD-ADULT Study Funded by $3.6 Million NIH Grant
    Media name/outletNasdaq
    Country/TerritoryUnited States
    Date13/01/25
    URLct.moreover.com/?a=55763272814&p=1gw&v=1&x=44RsGP0LpxqdIiRAxDmpsw
    PersonsKevin Chung
  • TitleFDA Approves Feasibility Study with SeaStar Medical's Selective Cytopheretic Device in Adults with Cardiorenal Syndrome
    Media name/outletManila Times
    Country/TerritoryPhilippines
    Date13/01/25
    URLct.moreover.com/?a=55763125759&p=1gw&v=1&x=uupeYqg8VPDx9Nv0iYLagQ
    PersonsKevin Chung
  • TitleFDA Approves Feasibility Study with SeaStar Medicals Selective Cytopheretic Device in Adults with Cardiorenal Syndrome
    Media name/outletMarket News Publishing
    Country/TerritoryUnited States
    Date13/01/25
    PersonsKevin Chung
  • TitleFDA Approves Feasibility Study with SeaStar Medical’s Selective Cytopheretic Device in Adults with Cardiorenal Syndrome
    Media name/outletBioSpace
    Country/TerritoryUnited States
    Date13/01/25
    URLct.moreover.com/?a=55763622901&p=1gw&v=1&x=RD6V21yirOhOcHHbjaS9rg
    PersonsKevin Chung
  • TitleFDA Approves Feasibility Study with SeaStar Medical’s Selective Cytopheretic Device in Adults with Cardiorenal Syndrome
    Media name/outletGlobeNewswire
    Country/TerritoryUnited States
    Date13/01/25
    PersonsKevin Chung
  • TitleSeaStar Medical Holding Corporation: FDA Approves Feasibility Study with SeaStar Medical's Selective Cytopheretic Device in Adults with Cardiorenal Syndrome
    Media name/outletFinanzNachrichten.de
    Country/TerritoryGermany
    Date13/01/25
    URLct.moreover.com/?a=55763497367&p=1gw&v=1&x=4HOjtlWcx5SqR8YoV-THmQ
    PersonsKevin Chung
  • TitleFDA Approves Feasibility Study with SeaStar Medical’s Selective Cytopheretic Device in Adults with Cardiorenal Syndrome
    Media name/outletUSTimesGazette.com
    Country/TerritoryUnited States
    Date13/01/25
    URLct.moreover.com/?a=55762969263&p=1gw&v=1&x=FUGJVHjvd4V38Ore43fjWw
    PersonsKevin Chung
  • TitleFDA Approves Feasibility Study with SeaStar Medical’s Selective Cytopheretic Device in Adults with Cardiorenal Syndrome
    Media name/outletSMBandMe.com
    Country/TerritoryUnited States
    Date13/01/25
    URLct.moreover.com/?a=55762986540&p=1gw&v=1&x=SYb2VkbtMvFypTOWNcbIfg
    PersonsKevin Chung
  • TitleFDA Approves Feasibility Study with SeaStar Medical’s Selective Cytopheretic Device in Adults with Cardiorenal Syndrome
    Media name/outletNewsR.in
    Country/TerritoryIndia
    Date13/01/25
    URLct.moreover.com/?a=55762791936&p=1gw&v=1&x=QfcSeRo4S40xjrN9qg6GnQ
    PersonsKevin Chung